Akso Health Group (AHG) director submits initial Form 3 filing

Rhea-AI Filing Summary

Akso Health Group director Xu Jianqiang has filed an initial statement of beneficial ownership on Form 3. The filing lists him as a director but shows no reportable transactions, no derivative positions and no share holdings in the summarized data at this time.

Key Terms

Form 3, reportingPersons, beneficial ownership

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3): initial statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reportingPersons regulatory

""reportingPersons": [{"name": "Xu Jianqiang", ... }]"

beneficial ownership financial

"initial statement of beneficial ownership on Form 3 for a director"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Xu Jianqiang

(Last) (First) (Middle)

2ND FLOOR,QIANTONGYUAN BUILDING,

NO.44,MOSCOW ROAD,

(Street)

QINGDAO 266000

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/30/2026

3. Issuer Name and Ticker or Trading Symbol
Akso Health Group [ AHG ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	Jianqiang Xu	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Xu Jianqiang’s Form 3 filing for Akso Health Group (AHG) show?

The Form 3 filing shows that Xu Jianqiang is a director of Akso Health Group. It is an initial statement of beneficial ownership and, in the summarized data provided, reports no transactions, share holdings, or derivative positions at this time.

Does the Akso Health Group (AHG) Form 3 report any insider share purchases or sales?

No insider share purchases or sales are reported in this Form 3 for Akso Health Group. The transaction summary fields for buys, sells, exercises, gifts, tax withholding and restructurings all show zero counts and zero shares in the provided data.

What role does the reporting person hold at Akso Health Group (AHG)?

The reporting person, Xu Jianqiang, is identified as a director of Akso Health Group. The Form 3 flags him as a director, while not indicating any officer position, ten percent ownership status, or other roles in the structured data shown.

Are there any derivative securities reported in this Akso Health Group (AHG) Form 3?

No derivative securities are reported in this Form 3 for Akso Health Group. The derivative summary is empty, and the transaction summary indicates zero derivative transactions and zero exercise shares within the available filing data.

What is the purpose of this Form 3 related to Akso Health Group (AHG)?

This Form 3 serves as an initial statement of beneficial ownership for director Xu Jianqiang at Akso Health Group. It formally registers his insider status, even though the summarized data shows no current transactions, holdings or derivative positions being reported.